FOCUS ON US Program for Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called FOCUS ON US to evaluate its effectiveness for cancer patients who identify as sexual or gender minorities, such as LGBTQ+ individuals, and their unpaid caregivers. The goal is to determine the program's practicality and helpfulness by comparing those who start immediately with those who wait. Participants must have been diagnosed with any invasive cancer within the last two years and have a caregiver willing to join. This trial suits individuals who can communicate in English and reside in the United States. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance support for diverse communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the FOCUS ON US intervention is safe for cancer patients?
Research has shown that the FOCUS ON US program is based on the proven FOCUS program used in cancer care, utilizing methods that have been successful before. However, specific safety information for FOCUS ON US itself is not available.
The trial phase is marked as "Not Applicable," indicating that the program is likely a supportive program or therapy rather than a drug. Such programs typically carry fewer risks than drug treatments.
The FOCUS program has been used successfully in cancer care, suggesting it is generally well-received. However, without specific data, it is important to remember that each person's experience may differ. Participants should discuss any concerns with the trial team before joining.12345Why are researchers excited about this trial?
Researchers are excited about the FOCUS ON US program because it offers a fresh approach to supporting cancer patients. Unlike traditional treatments that mainly target the disease itself, this program focuses on enhancing the overall well-being and mental health of patients. By integrating immediate intervention and follow-up assessments, it aims to provide continuous support and improve the quality of life for those undergoing cancer treatment. This holistic approach could potentially lead to better patient outcomes and satisfaction, making it a promising addition to the current cancer care landscape.
What evidence suggests that the FOCUS ON US intervention could be effective for cancer patients?
Research has shown that the FOCUS program, which serves as the basis for the FOCUS ON US intervention, has been promising in helping cancer patients. It aims to improve crucial areas such as emotional well-being and quality of life, which can enhance treatment effectiveness. Participants in this trial will either receive the FOCUS ON US intervention immediately or join a waitlist control group. Patient stories and clinical assessments suggest that programs like this can improve the cancer treatment experience. Although specific data on FOCUS ON US is not yet available, its foundation in the well-regarded FOCUS program is encouraging.36789
Are You a Good Fit for This Trial?
This trial is for sexual and/or gender minority (SGM) cancer patients, such as those who identify as lesbian, gay, bisexual, transgender, queer etc., along with their informal caregivers. A total of at least 160 participants will be involved.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention group receive the FOCUS On Us program immediately after baseline assessment
Follow-up
Participants are monitored for outcomes and satisfaction 3 months after completing the intervention
Waitlist Control
Participants in the waitlist control group complete a baseline assessment and receive the intervention after a 6-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- FOCUS ON US
Trial Overview
The study tests the adapted FOCUS On Us program against a waitlist control in a two-arm pilot trial to see if it's feasible and acceptable for SGM cancer patients and their caregivers.
How Is the Trial Designed?
2
Treatment groups
Active Control
This group will complete a baseline assessment and then receive the intervention immediately. Participants will complete a post-intervention assessment survey after completing the intervention. Finally, participants will be contacted for a follow-up assessment 3 months after finishing the intervention.
This group will create a baseline assessment and will not receive the intervention. Participants will complete a post-intervention assessment survey \~3 months after baseline. Following a \~6-month (from baseline) follow-up assessment, this group will be offered the intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Charles Kamen
Lead Sponsor
Wayne State University
Collaborator
National Cancer Institute (NCI)
Collaborator
Citations
National Estimates of the Participation of Patients With ...
The overall estimated patient participation rate to cancer treatment trials was 7.1%. Patients with cancer participated in a wide variety of other studies.
Outcomes that matter to patients with cancer: living longer and ...
Oncologists and cancer patients generally agree that the primary goals of cancer treatment are to lengthen survival and, especially in the advanced disease ...
3.
cancerresearch.org
cancerresearch.org/media-room/the-2024-impact-report-of-the-cancer-research-instituteThe 2024 Impact Report of the Cancer Research Institute
CRI's 2024 Impact Report highlights progress in cancer immunotherapy research and shares inspiring patient stories.
Core Patient-Reported Outcomes in Cancer Clinical Trials
This guidance provides recommendations to sponsors for collection of a core set of patient- reported clinical outcomes (herein referred to as core patient- ...
5.
aacrjournals.org
aacrjournals.org/clincancerres/article/22/7/1553/122129/Focusing-on-Core-Patient-Reported-Outcomes-inFocusing on Core Patient-Reported Outcomes in Cancer ...
Clinical outcome assessments, such as PRO, can provide important data to support the safety and efficacy of a cancer treatment. Accordingly, we should ...
Patient Focus
88,000 patients enrolled in cancer clinical trials to date · Contributed to more than 100 FDA-approved cancer therapies · Hundreds of research programs enrolling ...
OCE Patient-Focused Drug Development Program
The PFDD Program identifies rigorous methods to assess the patient experience which complements existing survival and tumor information.
Home - National Cancer Institute
The EBCCP (formerly RTIPs) website is a searchable database of evidence-based cancer control programs and is designed to provide program planners and public ...
9.
globalforum.diaglobal.org
globalforum.diaglobal.org/issue/june-2021/patient-focused-initiatives-in-oncology-how-the-us-government-paved-the-way/Patient-Focused Initiatives in Oncology
The intent of this online platform, called Project Patient Voice, is to make patient-reported symptom data derived from clinical trials supporting approved ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.